StockData
Jupiter Neurosciences, Inc. logo

Jupiter Neurosciences, Inc. (JUNS) stock

JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$1.70−0.06 (-3.41%)

Close on Nov 16, 2026Market cap $1.31MP/E –Yield –

Jupiter Neurosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Jupiter Neurosciences's enterprise value was -$99.48K on Nov 11, 2026, against $41.30M a year earlier. Over the last 2 years it ranged from -$159.30K to $322.43M, with a median of $17.67M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$99.48K-100.3%
2025Dec 31, 2025$34.27M-89.4%
2024Dec 31, 2024$322.43M–

More Jupiter Neurosciences figures

See a number that looks wrong?